Company intelligence / Profile preview

Instituto de Medicina Regenerativa

Tijuana, Baja California, Mexicocirm.ca.gov ↗

Ownership: Private
Development stage: Other

Overview

Instituto de Medicina Regenerativa is an active healthcare organization specializing in regenerative medicine. It operates a world-class center in Tijuana, Mexico focused on autologous adipose-derived stem cell implantation for cardiac conditions. The institute has received national recognition for its cardiology research. In addition to clinical services, it has at least one early-phase oncology program developing a personalized neoantigen peptide vaccine targeting neoplasms.

Therapeutic areas: CardiovascularOncology
Modalities: Stem cell therapyCell therapyTherapeutic vaccinePlatelet-rich plasma therapy
Industry: Biotech

Drug pipeline

1 asset

umbilical cord mesenchymal stem cells (Instituto de Medicina Regenerativa)

Unknown

Beyond the preview

Go deeper on Instituto de Medicina Regenerativa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Instituto de Medicina Regenerativa.

Explore the full profile